Yield10 Bioscience Initiates Early Development Program in Corn to Evaluate Novel Traits
Under this program, novel traits discovered by Yield10 will be deployed in corn by a third-party agriculture company with proven expertise introducing new traits into corn. This aspect of the development activity is expected to be completed in early 2020. Yield10 plans to engage an additional third-party to conduct field testing of the novel traits in corn to evaluate the impact on seed yield.
“Historically, advances in corn seed yield have been based on the development of hybrids and crop protection strategies that prevent yield losses caused by the presence of excessive weeds or insect pests,” said
Corn is planted on approximately 90 million acres and is the highest value crop in
“The start of our development program in corn is a key milestone for Yield10 as it places us on the path toward commercialization of our novel yield traits in this important crop,” said
The yield traits included in the corn development program are C3003, C3004, and C3011, as well as the transcription factors C4001, C4002, and C4003. C3003, a gene found in algae, has produced encouraging improvements in seed yield in oilseed crops. The trait C3004 will also be evaluated in corn, based on encouraging seed yield results obtained in Camelina. C3011 is a new trait developed in Yield10’s GRAIN gene discovery platform. The Company previously reported that the C4000 series of traits, which include global regulatory genes, or global transcription factors (“GTFs”), can significantly increase photosynthesis and biomass yield in studies utilizing switchgrass as a model crop. Biotech traits based on microbial genes, as well as plant gene traits, which have the potential to be non-regulated by deploying them using cis-genic or CRISPR-Cas9 genome-editing approaches, will be tested in Yield10’s corn program.
For more information about the company, please visit www.yield10bio.com.
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical, including, without limitation, statements regarding the Company's intentions with regard to achieving the research objectives in the corn program, including its ability to produce new varieties of corn that are higher yielding and/or drought tolerant, continuing to generate key proof points in crops of high commercial interest, the potential for additional plant gene traits to be non-regulated, the timing for completion of the first steps in the early development program in corn, and the pursuit of licensing opportunities for corn, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including the risks and uncertainties detailed in
Investor Relations Contact:
Managing Director, CORE IR
FischTank Marketing and PR
Source: Yield10 Bioscience, Inc.